Phase I study of camrelizumab in patients with advanced solid tumors

被引：0
|
作者：
Yuxiang Ma
Jiaxin Cao
Yang Zhang
Qianwen Liu
Wenfeng Fang
Yunpeng Yang
Yuanyuan Zhao
Qing Yang
Hongyun Zhao
Li Zhang
机构：
[1] Sun Yat-sen University Cancer Center,Department of Clinical Research
[2] State Key Laboratory of Oncology in South China,Department of Medical Oncology
[3] Collaborative Innovation Center for Cancer Medicine,undefined
[4] Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy,undefined
[5] Sun Yat-sen University Cancer Center,undefined
[6] State Key Laboratory of Oncology in South China,undefined
[7] Collaborative Innovation Center for Cancer Medicine,undefined
[8] Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy,undefined
[9] Jiangsu Hengrui Medicine Co. Ltd,undefined
来源：
Signal Transduction and Targeted Therapy | / 8卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] A Phase I study of pazopanib in combination with gemcitabine in patients with advanced solid tumors
    Ruth Plummer
    Ayman Madi
    Melinda Jeffels
    Heike Richly
    Bahar Nokay
    Stephen Rubin
    Howard A. Ball
    Steve Weller
    Jeffrey Botbyl
    Diana M. Gibson
    Max E. Scheulen
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 93 - 101
  • [22] A phase I study of ridaforolimus in adult Chinese patients with advanced solid tumors
    Liu, Lian
    Zhang, Wen
    Li, Wenhua
    Lv, Fangfang
    Xia, Zuguang
    Zhang, Sheng
    Liu, Wen
    Zandvliet, Anthe S.
    Waajen, Sylvia
    Zhang, Li Xin
    Yan, Li
    Li, Jin
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2013, 6
  • [23] A Phase I study of sorafenib in combination with capecitabine in patients with advanced, solid tumors
    Awada, A.
    Gil, T.
    Burk, K.
    Vanhamme, J.
    Mancini, I.
    Besse, T.
    Brendel, E.
    Matthys, A.
    Piccart, M.
    Hendlisz, A.
    EJC SUPPLEMENTS, 2006, 4 (12): : 33 - 34
  • [24] Phase I study of recombinant human endostatin in patients with advanced solid tumors
    Herbst, RS
    Hess, KR
    Tran, HT
    Tseng, JE
    Mullani, NA
    Charnsangavej, C
    Madden, T
    Davis, DW
    McConkey, DJ
    O'Reilly, MS
    Ellis, LM
    Pluda, J
    Hong, WK
    Abbruzzese, JL
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (18) : 3792 - 3803
  • [25] A phase I study of bortezomib plus irinotecan in patients with advanced solid tumors
    Ryan, David R.
    O'Neil, Bell H.
    Supko, Jeffrey G.
    Lima, Carlo M. Rocha
    Dees, E. Claire
    Appleman, Leonard J.
    Clark, Jeffrey
    Fidias, Phinos
    Orlowski, Robert Z.
    Kashala, Oscar
    Eder, Joseph R.
    Cusack, James C., Jr.
    CANCER, 2006, 107 (11) : 2688 - 2697
  • [26] A Phase I Study of Sunitinib Plus Capecitabine in Patients With Advanced Solid Tumors
    Sweeney, Christopher J.
    Chiorean, E. Gabriela
    Verschraegen, Claire F.
    Lee, Fa Chyi
    Jones, Suzanne
    Royce, Melanie
    Tye, Lesley
    Liau, Katherine F.
    Bello, Akintunde
    Chao, Richard
    Burris, Howard A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (29) : 4513 - 4520
  • [27] A phase I QTc study of tivozanib in patients with advanced solid tumors.
    Chadha, Manpreet Kaur
    Infante, Jeffrey R.
    Cotreau, Monette M.
    Jacobson, Lindsey
    Strahs, Andrew Louis
    Slichenmyer, William
    Vargo, Dennis
    Moore, Kathleen N.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [28] Phase I study of sapacitabine and seliciclib in patients with advanced solid tumors.
    Tolaney, Sara M.
    Hilton, John Frederick
    Cleary, James M.
    Gandhi, Leena
    Kwak, Eunice Lee
    Clark, Jeffrey W.
    Wolanski, Andrew
    Bell, Tracy Demeo
    Rodig, Scott J.
    Chiao, Judy H.
    Blake, David
    Shapiro, Geoffrey
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [29] A phase I study of bizelesin (NSC 615291) in patients with advanced solid tumors
    Pitot, HC
    Reid, JM
    Sloan, JA
    Ames, MM
    Adjei, AA
    Rubin, J
    Bagniewski, PG
    Atherton, P
    Rayson, D
    Goldberg, RM
    Erlichman, C
    CLINICAL CANCER RESEARCH, 2002, 8 (03) : 712 - 717
  • [30] A phase I study of Triapine® in combination with doxorubicin in patients with advanced solid tumors
    William R. Schelman
    Sherry Morgan-Meadows
    Rebecca Marnocha
    Fred Lee
    Jens Eickhoff
    Wei Huang
    Marcia Pomplun
    Zhisheng Jiang
    Dona Alberti
    Jill M. Kolesar
    Percy Ivy
    George Wilding
    Anne M. Traynor
    Cancer Chemotherapy and Pharmacology, 2009, 63 : 1147 - 1156
12345